The skyrocketing demand for telemedicine and expansion of reimbursement for telehealth visits due to COVID-19 is likely going to shift the paradigm for diabetes care delivery into the future, setting
[Amazon.com Inc.] started selling its own diabetes test strips and glucose meters under the brand name Choice on Oct. 24. The company partnered with Arcadia Group on products for diabetic patients a
Although there may be some consolation in knowing that other segments of the device industry are experiencing similar challenges, the big players in the blood glucose meter (BGM) market are facing mar
Three years into the Patient Protection and Affordable Care Act (ACA), the biopharma industry, like much of corporate America, is struggling to assess whether it gains from the Act or loses. The negat